Manfré Luigi
Department of Minimal Invasive Spine Therapy, Cannizzaro Hospital; Catania, Italy -
Interv Neuroradiol. 2014 Oct 31;20(5):626-31. doi: 10.15274/INR-2014-10052. Epub 2014 Oct 17.
Lumbar spinal canal stenosis (LSCS) is one of the most common degenerative diseases in elderly patients. Failure of he treatment can occur, generally related to bone remodelling/fracture of spinous processes. PMMA augmentation of the posterior arch (spinoplasty, SP) has recently been proposed in case of neoplastic involvement. This study evaluated the efficacy of SP as a prophylactic treatment before introducing an interspinous spacer (IS). Moreover, we consider the possibility to treat patients who previously underwent IS implants with subsequent failure of the device, by introducing a second spacer at the same level, performing accessory SP. From January 2009 to September 2011, 174 patients with LSCS underwent CT-guided percutaneous IS implant in our department. From January 2011, all patients with osteoporosis underwent prophylactic SP before introducing the spacer. Moreover, in patients with re-stenosis related to bone remodelling and/or fracture, after strengthening the spinous processes with PMMA introduction, a second similar device was introduced to re-open the stenotic spinal canal. In patients with prophylactic treatment before spacer introduction, no restenosis occurred at three to 12 month follow-up. Patients who underwent second spacer implant at the same level after posterior arch augmentation again obtained a resolution of symptoms, and no further bone remodelling had occurred at follow-up controls. In conclusion, prophylactic SP prevents single spacer failure for bone remodelling/fracture, and allows failure repair by introducing a second spacer at the same level.
腰椎管狭窄症(LSCS)是老年患者中最常见的退行性疾病之一。治疗可能会失败,通常与棘突的骨质重塑/骨折有关。对于肿瘤累及的情况,最近有人提出采用聚甲基丙烯酸甲酯(PMMA)增强后弓(椎板成形术,SP)。本研究评估了SP作为预防性治疗在植入棘突间间隔器(IS)之前的疗效。此外,我们考虑对于先前植入IS但装置随后失效的患者,通过在同一水平引入第二个间隔器并进行辅助SP来进行治疗的可能性。2009年1月至2011年9月,174例LSCS患者在我科接受了CT引导下经皮IS植入。从2011年1月起,所有骨质疏松患者在引入间隔器之前均接受了预防性SP。此外,对于与骨质重塑和/或骨折相关的再狭窄患者,在通过引入PMMA强化棘突后,引入第二个类似装置以重新打开狭窄的椎管。在引入间隔器之前接受预防性治疗的患者中,在3至12个月的随访中未发生再狭窄。在进行后弓增强后在同一水平接受第二个间隔器植入的患者症状再次得到缓解,并且在随访检查中未发生进一步的骨质重塑。总之,预防性SP可防止单个间隔器因骨质重塑/骨折而失效,并通过在同一水平引入第二个间隔器来修复失效。